东曜药业-B（01875）公告将寻求股东大会授权，按不超过已发行股份（不包括库存股份）总数的10%进行股份购回。截至最后实际可行日期，公司已发行股份为772,787,887股。若授权获股东批准，公司最高可回购77,278,788股。
公司透露，拟从其可合法动用的资金中拨付购回款项，具体依据香港适用法律及公司组织章程细则。董事会认为，此举有助于调整资本结构并提高股东回报，符合公司及全体股东的最大利益。
公告显示，公司计划于2026年6月26日召开股东周年大会，就包括股份购回授权在内的多项决议进行审议并表决。同时，公司将于6月23日至6月26日期间暂停办理股份过户登记手续。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.